Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.

Lyft (LYFT) is a multimodal transportation network in the United States and Canada. It offers access to a variety of ...